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The discovery of active brown adipose tissue (BAT) in healthy adult humans has renewed
interest in the biology of this organ. BAT is capable of distributing nutrient energy in the
form of heat allowing small mammals to efﬁciently defend their body temperature when
acutely exposed to the cold. On the other hand BAT might be a target for the treatment
of obesity and related diseases, as its pharmacological activation could allow release of
excess energy stored inwhite adipose tissue depots. Energy dissipation in BAT depends on
the activity of uncoupling protein 1 (UCP1), therefore a BAT-based obesity therapy requires
a detailed understanding of structure and function of UCP1. Although UCP1 has been in the
focus of research since its discovery, central questions concerning its mechanistic function
and regulation are not yet resolved. They have been addressed in native mitochondria but
also in several test systems, which are generally used to lower inter-experimental variability
and to simplify analysis conditions. Different test systems have contributed to our current
knowledge about UCP1 but of course all of them have certain limitations.We here provide
an overview about research on UCP1 structure and function in test systems. So far, these
have nearly exclusively been employed to study rodent and not human UCP1. Considering
that the amino acid sequence of mouse and human UCP1 is only 79% identical, it will be
essential to test whether the human version has a similarly high catalytic activity, allowing
a relevant amount of energy dissipation in human BAT. Besides the issue of comparable
mechanistic function a sufﬁciently high expression level of human UCP1 is a further pre-
requisite for anti-obesity therapeutic potential. Treatments which induce BAT hyperplasia
and UCP1 expression in humans might therefore be equally important to discover as mere
activators of the thermogenic process.
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INTRODUCTION
Brown adipose tissue (BAT) is the exclusive site of cold induced
non-shivering thermogenesis in mammals and combusts stored
nutrient energy as heat (Smith, 1961). In cold exposed rodents, this
powerful process can claim more than a quarter of cardiac output
and more than half of total oxygen consumption, thereby facilitat-
ing heat dissipation up to nearly 500mW per gram tissue (Foster
and Frydman, 1978, 1979; Trayhurn and James, 1978; Puchalski
et al., 1987). To achieve this unique capability, brown adipocytes
are equipped with a specialized set of cellular features includ-
ing a large number of mitochondria with dense cristae, multiple
small lipid droplets providing high lipolytic rates, high nutrient
uptake rates and many more. In the center of all these processes,
however, a single essential protein facilitates the crucial mech-
anism of regulated mitochondrial proton leak across the inner
membrane: uncoupling protein 1 (UCP1). Therefore, understand-
ing the structure–function-relationship of UCP1 is of paramount
importance to understand brown fat thermogenesis.
The signiﬁcance of elucidating UCP1 function for biomedical
applied science has recently been highlighted by the (re)discovery
of active BAT in humans. Radiologists applying ﬂuorodeoxyglu-
cose positron emission tomography (FDG PET) combined with
computerized tomography (CT) during tumor diagnosis acciden-
tally visualized the in vivo distribution and activity of BAT (Hany
et al., 2002). However, the detailed anatomy of human BAT had
already been described as early as 1972 and a role of this tissue in
diet-induced obesity proposed several years later (Heaton, 1972;
Rothwell and Stock, 1979). The allometric comparison of BAT
mass and norepinephrine induced thermogenesis capacity across
multiple species predicts that mammals larger than 10 kg should
have no or insigniﬁcant amounts of BAT thermogenesis (Held-
maier, 1971). Accordingly, an a priori thermogenic function to
defend normothermia in the face of low ambient temperatures
is questionable in man. Indeed, estimating the contribution of
BAT to cold induced thermogenesis leads to a marginal to neg-
ligible fraction (Klingenspor and Fromme, 2012). However, the
discovered amounts of BAT are sufﬁcient to burn more than 4 kg
of fat during 1 year and may thus very well be a component of
organismic energy balance control (Virtanen et al., 2009). More-
over, the targeted pharmacological activation of brown fat energy
dissipation is a promising strategy to combat the global obesity epi-
demic and its associated diseases, but requires understanding how
exactly UCP1 structure enables its unique, regulated uncoupling
property.
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THERMOGENIC FUNCTION OF BAT
While white adipose tissue stores energy in form of triglycerides,
BAT is an energy-dissipating organ. Brown adipocytes contain a
high number of mitochondria and these contain vast amounts of
UCP1 totalling up to 5–8% of mitochondrial protein (Lin and
Klingenberg, 1980). Usually the mitochondrial inner membrane
is the place where ﬁnal conversion of nutrient energy into ATP
occurs. Combustion of lipids, carbohydrates and proteins results
in the production of reduction equivalents, which feed electrons
into the respiratory chain. Electrons are passed along a redox
gradient until they ﬁnally reduce oxygen to water. The energy
liberated by the redox reactions drives the export of protons from
thematrix into the intermembrane space, creating a protonmotive
force across the membrane. The ATP synthase utilizes the energy
conserved in the proton gradient and phosphorylates ADP to ATP.
In BAT this energy ﬁxation can be interrupted and metaboliza-
tion of substrates leads to a sustained direct conversion of nutri-
ent energy to heat. Upon adrenergic stimulation lipases mobilize
fat from lipid droplets and free fatty acids are rapidly metabo-
lized. Due to the presence of UCP1 in the inner mitochondrial
membrane this does not result in ATP production, as UCP1 short-
circuits the cycling of protons, which usually couples respiratory
chain activity to ATP production (Figure 1). In non-stimulated
conditions UCP1 is probably inhibited by purine nucleotides, but
when activated by free fatty acids, catalyzes a proton ﬂux into the
mitochondrialmatrix. Thus, the liberation of fatty acids upon cold
stimulation fuels heat production dually, by serving as metabolic
substrate and by directly activating UCP1.
MOLECULAR ASPECTS OF UCP1 FUNCTION
Despite intense research on UCP1 function several questions con-
cerning its precise mechanism, which might affect its potential as
therapeutic target, are unresolved. For example it is still disputed if
UCP1 contributes to basal leak of BAT mitochondria, leaving the
question if UCP1 would just have to be present or also activated to
dissipate excess energy (Parker et al., 2009; Shabalina et al., 2010).
Regulators of UCP1 had been known even before the protein
itself was puriﬁed and sequenced. Until today the interaction with
the inhibitory nucleotides and especially the mechanism of activa-
tionby fatty acids is not ﬁnally understood.Thenucleotide binding
of UCP1 has been characterized by measuring GDP binding to
wildtype and mutated versions of the protein in heterologous
systems. This strategy identiﬁed an interacting region in the C-
terminal part of the protein as well as individual amino acid
residues distributed in the primary sequence providing charges for
the interaction with purine nucleotides (Modriansky et al., 1997;
Winkler et al., 1997; Echtay et al., 1998). According to the three-
dimensional model these residues position in close proximity to
each other.
There are different models concerning the activation of UCP1
by fatty acids, being elaborations of two main hypotheses, one
claiming that fatty acids are cofactors, needed to form the trans-
port channel for the protons or to overcome nucleotide inhibition
(Winkler and Klingenberg, 1994; Klingenberg and Huang, 1999;
Shabalina et al., 2004), the other one stating that fatty acids are the
substrate of transport. According to this model fatty acid anions
would be transported to the intermembrane space by UCP1 and
protonated fatty acids would ﬂip–ﬂop back into the matrix to
complete proton translocation (Skulachev, 1991; Jezek et al., 1994;
Garlid et al., 1998).
So far only one member of the mitochondrial anion trans-
porter family, the ANT, has been crystallized. Three-dimensional
models of UCP1 are calculated based on its sequence and the
ANT structure, but of course might not reﬂect the actual situation
in the membrane. ANT was crystallized as a monomer whereas
almost since the beginning of UCP1 research it was assumed that
it functions as a homodimer. This was based on GDP binding
stoichiometry, sedimentation analyses, and cross-linking studies
(Lin et al., 1980; Lin and Klingenberg, 1982). In a recent review
all these ﬁndings were carefully reanalyzed, explaining why these
results might have been obtained even though UCP1 in BAT mito-
chondria works as monomer, for example by artiﬁcial aggregation
in detergents or overestimation of protein content in the presence
of detergent (Kunji and Crichton, 2010). Knowing the structure of
the wildtype protein or having the ability to compare it to mutant
versions of the protein would greatly facilitate to clarify how UCP1
interacts with its known inhibitors and activators or to predict
which novel substances might also be able to interact.
Knowledge about protein structure and interacting molecules
might also help to learn more about the physiological function of
UCP1. It has been shown thatUCP1 canbe activated by superoxide
and reactive alkenals, supporting an involvement in the protection
against reactive oxygen species (ROS) damage, according to the
mild uncoupling theory (Skulachev, 1996). Functional analysis of
isolated BAT mitochondria from wildtype and UCP1 knockout
animals supports this theory, as under basal conditions mito-
chondria from wildtype animals produce less ROS than knockout
animals, but reach the same level of ROS production when UCP1
is inhibited by addition of GDP (Oelkrug et al., 2010).
UCP1 ORTHOLOGS AND PARALOGS
Among the UCP1 orthologs rodent UCP1 is the best character-
ized uncoupling protein but studies of other UCP orthologs and
paralogs will be instrumental to elucidate structure–function-
relationships. Comparison of the characteristics of uncoupling
proteins from different species may reveal potentially crucial con-
served residues or domains of which the functional relevance can
be tested in targeted mutagenesis studies.
The paralogs UCP2 and UCP3 were discovered due to sequence
similarity with UCP1, with 59% for UCP2 and 57% for UCP3
(Boss et al., 1997; Fleury et al., 1997;Gimeno et al., 1997). They dif-
fer in their tissue speciﬁc expression pattern, as UCP3 is expressed
in skeletal muscle, heart and BAT, and UCP2 in multiple tissues,
with an important role in immune cells and in beta cells (Pecqueur
et al., 2001). For both paralogs no deﬁnite physiological function
could be assigned as the respective knockoutmodels do not display
a clear phenotype (Brand and Esteves, 2005). UCP3 expression is
elevated in physiological situations where free fatty acid levels in
plasma are elevated. This led to the assumption that UCP3 plays
a role in fatty acid metabolism. The fact that the UCP3 knock-
out mouse is not prone to 3,4-methylenedioxymethamphetamine
(MDMA)-induced hyperthermia hinted toward an involvement
in thermoregulation. There are several studies showing that UCP2
plays a role in beta cell function and affects glucose stimulated
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insulin secretion. Both UCP2 and UCP3, like UCP1, are supposed
to protect the cell from excessive production of ROS according to
the mild uncoupling theory (Skulachev, 1996). The regulation of
the activity of UCP2 and UCP3 seems to differ from UCP1, as
they are activated by superoxide and reactive alkenals but not by
fatty acids alone. UCP1 orthologs for which uncoupling function
has been analyzed, including carp UCP1 (Jastroch et al., 2007),
elephant shrew UCP1 (Mzilikazi et al., 2007) and marsupial UCP1
(Polymeropoulos et al., 2011), can be used for comparisons of
structure and function. It will be stressed in this review that valid
comparisons require the use of suitable expression systems, as oth-
erwise the proteins are characterized on a different mitochondrial
background which might contribute to differences in function not
related to protein structure. There are also several studies on BAT
in larger mammals, like sheep and bovine, which are only exposed
to thermal stress after birth and during early juvenile develop-
ment but not in their adult life history. These studies mainly focus
on the aspect of emergence and persistence of the tissue during
the postnatal phase and juvenile development (Carstens, 1994;
Symonds et al., 2011; Taga et al., 2011), rather than directly testing
the function of the uncoupling protein.
HUMAN BAT AND MOLECULAR ASPECTS OF HUMAN UCP1
From a biomedical perspective it is certainly of capital impor-
tance to study the human UCP1 protein and its function. This
may not be obvious on the ﬁrst glance but, e.g., mouse and
human UCP1 only share less than 80% identity on the amino
acid level. The initial three reports of signiﬁcant amounts of active
human BAT in 2009 conﬁrmed the presence of mRNA and pro-
tein of human UCP1 in human BAT by immunohistochemistry
andquantitative PCR, respectively (Cypess et al., 2009; vanMarken
Lichtenbelt et al., 2009; Virtanen et al., 2009). These ﬁndings have
since been reproduced multiple times (Saito et al., 2009; Zingaretti
et al., 2009; Svensson et al., 2011). Earlier, human patients with
pheochromocytoma have been studied, a neuroendocrine disease
leading to excessive release of catecholamines and the appearance
of BAT-like tissue depots in the body. Samples of this periadrenal,
perirenal, and omental tissue express ∼30μg UCP1/mg mito-
chondrial protein, which is a concentration comparable to the
expression in the interscapular BAT of mice acclimated to room
temperature (Table 1; Lean et al., 1986a). Healthy control subjects,
however, express only ∼3μg UCP1/mg mitochondrial protein in
perirenal and axillary fat depots (Lean et al., 1986b). It is unclear
whether this low concentration is due to a dilution of brown with
white adipocyte mitochondria or indeed a far lower level of UCP1
expression in brown adipocytes. Furthermore, other human fat
depots not studied so far may display very different UCP1 expres-
sion. Even less is known about human UCP1 on the level of
functional or mechanistic studies and it remains elusive whether
human UCP1 is similarly effective and tightly regulated as its well-
studied rodent counterparts. We would like to emphasize the need
to remedy this deﬁcit and in the followingwe systematically present
test systems currently available for this challenging task.
TEST SYSTEMS FOR UCP1 FUNCTION
Several test systems have been applied in research on UCP1 func-
tion, such as proteoliposomes, yeast, and mammalian cells, includ-
ing brown adipocytes. Initial studies depended on animal tissue as
the sole source forUCP1. Theywere conductedwithmitochondria
isolated from animals after exposure to different treatments (cold
exposure, high fat diet feeding, drug application) to alter UCP1
expression, or with UCP1 ﬁrst puriﬁed from mitochondria and
then reconstituted in proteoliposomes. Cloning and sequencing
of UCP1 cDNA and protein (Aquila et al., 1985; Bouillaud et al.,
1986) enabled the use of heterologous expression systems either as
a source for the puriﬁed protein or as a source for mitochondria
containing UCP1 at variable concentrations. With these systems
it was possible to study the consequences of mutations inserted
Table 1 | Comparison of maximum UCP1-dependent H+ transport rates in different test systems.
System UCP1 Mitoprotein
(μg/mg)
mV nmol H+∗ min−1∗ μg
UCP1−1∗ mV−1
H+∗ s−1 Reference
BAT mitochondria Hamster (cold) 54 180 0.05 5.0 Rial et al. (1983)
Mouse (RT) 29.8 141 0.02 1.7 Monemdjou et al. (1999)
Rat (RT) 13 143 0.56 44.0 Esteves et al. (2006)
Mouse (RT) 29.8 147 0.34 27.5 Shabalina et al. (2006)
Mouse (RT) 29.8 147 0.31 24.8 Parker et al. (2009)
Liposomes Rat expressed in yeast 1.2 Murdza-Inglis et al. (1991)
Hamster expressed in yeast 55.0 Echtay et al. (1998)
Rat expressed in E. coli 11.0 Jaburek and Garlid (2003)
Lipid bilayer Hamster 180 0.14 14.0 Urbankova et al. (2003)
Yeast mitochondria Mouse 0.9 138 9.28 704.0 Stuart et al. (2001)
HEK UCP1 mitochondria Mouse 4.8 155 0.88 74.8 Unpublished data
Brown fat cell mitochondria Mouse 2.8 141 1.17 90.8 Unpublished data
Values were extracted from tables and ﬁgures of publications and UCP1-dependent transport rates were calculated by subtracting respiration of mitochondria from
knockout animals or in the presence of GDP. Rates expressed as H+∗ s−1 are calculated from oxygen consumption rates (nmol O∗ min−1) and mitochondrial concen-
trations of UCP1 protein (μg/mg). Considering that maximum UCP1-dependent transport rates are determined at different membrane potentials all systems, except
yeast, for which an uncoupling artifact has been published, are in a comparable range.
www.frontiersin.org November 2011 | Volume 2 | Article 63 | 3
Hirschberg et al. UCP1 test systems
into the protein and to compare the properties of UCP orthologs
and paralogs. Since UCP1 knockout animals have been generated
(Enerback et al., 1997), comparison of the bioenergetic properties
of normal and UCP1-ablated brown fat mitochondria are another
valuable system to study UCP1 function.
In the following we will brieﬂy introduce the principle of
different test systems and their most frequent applications and
discuss their strengths and weaknesses (Table 2). Major insight
gained with these test systems concerning the structure–function-
relationship of UCP1 will be highlighted. Moreover, we provide a
comprehensive summary on which aspects of human UCP1 have
been studied so far using these test systems.
PROTEOLIPOSOMES
Liposomes are a standard tool to study the transport function
of membrane proteins. The protein(s) of interest are reconsti-
tuted into the bilayer phospholipid membrane of vesicles with a
diameter of 5–15 nm enclosing an aqueous compartment. This
membrane mimics the natural phospholipid environment, pro-
vides a lipophilic compartment for protein solubilization and
facilitates proper folding. Puriﬁed native proteins or recombi-
nantly expressed proteins can be inserted into this membrane by
mixing the components in the presence of detergent. Transport
characteristics of the inserted membrane protein can be studied
by loading the vesicles with speciﬁc buffers. Differential buffer
composition in- and outside of the vesicle generates the driving
force for subsequent experiments where ion ﬂux is measured. The
initial study reconstituting UCP1 in this system was published in
1983 (Bouillaud et al., 1983) followed by the demonstration of
H+ transport by UCP1 in proteoliposomes two years later (Klin-
genberg and Winkler, 1985). The ﬁrst successful reconstitution of
recombinant UCP1 from E. coli inclusion bodies was performed
by Jaburek and Garlid (2003), who could measure H+ transport
rates comparable to the reconstituted native UCP1 isolated from
hamster BAT.
Ion transport is usually detected by dyes, which are quenched
by a speciﬁc ion or which aggregate when proteoliposomes are
polarized. Therefore results are presented as relative transport
rates above basal or absolute ion transport rates per time and
mg reconstituted protein (Figure 2).
The main advantage of the proteoliposome system is that UCP
mutants as well as paralogs and orthologs can be directly com-
pared in an identical environment in the absence of secondary
inﬂuences on UCP function by other mitochondrial or cellular
processes. Variation due to different intactness of isolated mito-
chondria can be excluded and furthermore effects of membrane
composition can easily be tested.
A major disadvantage is the inconsistency of results for pro-
teoliposome studies coming from different labs. Variables like
protein source (native, recombinant fromyeastmitochondria or E.
coli inclusion bodies), isolation and puriﬁcation protocol (deter-
gents, puriﬁcation columns, dialysis steps), and reconstitution
conditions (membrane composition, removal of detergent) con-
tribute to highly divergent results concerning various aspects of
uncoupling protein function. For example, estimations of cor-
rect UCP orientation in vesicles vary between 50 and 85% and
transport rates in the range of 1.2–55H+∗ s−1 have been reported
(Murdza-Inglis et al., 1991; Echtay et al., 1998) (Table 1). Direct
comparison with native protein in the same setting seems to
be the most feasible approach to evaluate if appropriate experi-
mental conditions have been chosen. Otherwise, incorrect folding
or protein aggregation will not be recognized and lead to over-
or underestimation of transport activities. A further disadvan-
tage is that transport is analyzed at low driving force. This is a
major drawback as the regulation of UCP1 is strongly dependent
on membrane potential and shows strong increases in fatty acid
induced uncoupling at high driving forces.
Several important ﬁndings were achieved by the use of UCP1
proteoliposomes. It was demonstrated that UCP1 is indeed capa-
ble of catalyzing a net proton ﬂux and transport rates measured
argue for a carrier characteristic (Klingenberg andWinkler, 1985).
Furthermore, UCP1 molecules were cross-linked in the isolated
state, in mitochondria, and after reconstitution into liposomes
and in the liposome system it was shown that forced dimeriza-
tion does not impair activity, as two cross-linked molecules still
bind GDP and still display H+ transport (Klingenberg and Appel,
1989). Studies with fatty acids and modiﬁed analogs or cross-
linking of analogs to UCP1 set out to clarify whether fatty acids
are essential cofactors or if fatty acid anions are the substrate of
transport (Garlid et al., 1996; Jezek et al., 1996; Breen et al., 2006).
This question still has not been ﬁnally resolved. Liposomes were
also suggested to be a suitable test system for large scale screening
of molecules to identify novel regulators of UCP1 function (Mozo
et al., 2006).
Human UCP1 has been expressed in E. coli inclusion bodies
and reconstituted for circular dichroism spectroscopy in solu-
tion and in liposomes (Ivanova et al., 2010). Remarkably there
are no published functional studies in liposomes using the human
UCP1, although there are several studies comparing human UCP2
and human UCP3 with rodent UCP1. It seems that the obsolete
assumption of BAT disappearance shortly after birth in humans
has constrained investigations with the human protein.
PLANAR LIPID BILAYERS
Proteoliposomes spontaneously form a monolayer at the surface
of the suspension (Schindler, 1979). Planar lipid bilayers can be
formed by the combination of two such monolayers and then have
a capacity and dielectrical thickness which is comparable to bio-
logical membranes (Montal and Mueller, 1972). The conductance
of proteins integrated in these membranes can be analyzed by
recording the conductivity of the membrane with a patch clamp
ampliﬁer. The ﬁrst analysis of uncoupling proteins in this system
reconstituted puriﬁed hamster UCP1 and was performed in 2003
(Urbankova et al., 2003).
The activity of uncoupling proteins in a lipid bilayermembrane
is described in current voltage plots which can be used to calculate
transported molecules per molecule of the analyzed protein.
Planar lipid bilayer membranes have similar advantages like
proteoliposomes, as they allow comparison of different UCPs
in a deﬁned background, which can be varied, with respect to
membrane phospholipid composition, fatty acids or other protein
components. Furthermore, this system allows characterization of
the proteins over a broad range of voltages, as the driving force is
not applied by buffer loading, but by a voltage source.
Frontiers in Endocrinology | Cellular Endocrinology November 2011 | Volume 2 | Article 63 | 4
Hirschberg et al. UCP1 test systems
As in proteoliposomes the correct folding, insertion, and ori-
entation of puriﬁed, native or recombinant proteins into the
membrane is critical in this test system. The possibility that cofac-
tors are missing or artifactual transport is detected can hardly be
excluded.
With the planar lipid bilayer test system the transport rate of
UCP1 isolated from hamster BAT was 14H+∗ s−1 (Urbankova
et al., 2003; Table 1). It was shown that fatty acids are obligatory
cofactors forUCP1 function and that the activation by fatty acids is
membrane potential dependent (Rupprecht et al., 2010). Concern-
ing the debate on the transportmechanismbyUCP1,experimental
results from this system argue for facilitated ﬂip–ﬂop/transport
of deprotonated fatty acids to the intermembrane space. Lipid
containing bilayer membranes already display a certain proton
conductance,which is dependent on the potential above the mem-
brane. The co-incorporation of uncoupling proteins ampliﬁes
this conductance but does not change the membrane potential
dependent kinetics (Rupprecht et al., 2010).
Notably the function of human UCP1 has also been analyzed in
the planar lipid bilayer system by puriﬁcation and reconstitution
from E. coli inclusion bodies. Transport activity of human UCP1
was qualitatively similar to UCP1 isolated from Syrian hamster
BAT (Beck et al., 2006). Furthermore it was shown that polyunsat-
urated fatty acids activate human UCP1 and UCP2 in planar lipid
bilayers (Beck et al., 2007).
YEAST
Yeast as a prototypic eukaryoticmodel organism is easily accessible
to genomic modiﬁcations. The yeast genome does not contain a
UCP1 ortholog, which is a clear advantage for functional studies.
Like E. coli it can serve for recombinant overexpression of mem-
brane proteins as the starting material for functional studies in
proteoliposomes and planar lipid bilayers. Garlid and colleagues,
making use of the yeast system to ectopically express UCP1,
demonstrated that the protein isolated from yeast and reconsti-
tuted into proteoliposomes exhibited characteristics similar to the
native UCP1 isolated from BAT (Murdza-Inglis et al., 1991). This
opened up new opportunities for mutation studies, giving ﬁrst
insights into structure–function-relationships.
Besides serving for recombinant protein production intact cells
or isolated mitochondria from yeast expressing different UCPs can
be analyzed to identify consequences of UCP activity for growth,
cellular respiration or change of membrane potential asmonitored
by ﬂuorescent dyes.
Compared to the E. coli expression system yeast overcomes
the problem of puriﬁcation and reconstitution of membrane pro-
teins from inclusion bodies because it is a eukaryotic cell, where
heterologously expressed uncoupling proteins are inserted into
mitochondria, their native environment. Yeast can still be grown
easily in large scale, allowing the production of sufﬁcient amounts
of UCPs for analyses, with stable conditions. Various yeast strains
with deﬁciencies in possible cofactors are available and can be
used to test whether UCP1 function is affected in mitochondria of
such a strain. Studies on coenzyme Q deﬁcient strains, for exam-
ple, demonstrated that coenzyme Q is not a necessary cofactor for
uncoupling proteins (Esteves et al., 2004), thus supporting previ-
ous ﬁndings in proteoliposomes (Jaburek and Garlid, 2003). Yeast
has been used for a proteomic study, where the mitochondrial
proteome of yeast heterologously expressing UCP1 was compared
to that of wildtype yeast (Douette et al., 2006). UCP1 expression
leads to a slight increase in mitochondrial mass and upregulation
of proteins that help to maintain ATP levels despite uncoupling
activity.
Although being a eukaryotic cell, yeast is a single cell organ-
ism which precludes analysis of physiological functions of UCP1.
Furthermore, Stuart et al. (2001) demonstrated that expression of
UCP1 above 1μg/mg leads to an uncoupling artifact in isolated
mitochondria, probably due to improper folding or insertion of
the protein in the inner mitochondrial membrane. At a concentra-
tion of ∼30μg/mg UCP1 in brown fat mitochondria of mice kept
at room temperature exhibits a transport activity of ∼25H+∗ s−1,
whereas in yeast even without artifactual uncoupling the activity
was∼700H+∗ s−1 (Table 1).
Most of the structure–function studies on UCP1 have been
conducted in yeast. Mutated versions of UCP1 were expressed and
either characterized after reconstitution in liposomes or in iso-
lated yeast mitochondria. Of special interest is one study, where
protein domains were swapped between UCP1 and UCP3. Hagen
and Lowell (2000) demonstrated that the second part of the tripar-
tite structure of UCP1 is necessary and sufﬁcient for activation by
fatty acids, which was analyzed further by Jimenez-Jimenez and
colleagues. They demonstrated that it is the central matrix loop
of UCP1 which is required for fatty acid sensitivity. Exchange of
this part of the sequence with the corresponding UCP2 sequence
resulted in loss of fatty acid sensitivity (Jimenez-Jimenez et al.,
2006).
So far yeast has not been employed as a model organism to
study human UCP1 structure and function.
MAMMALIAN CELL LINES
Shortly after the availability of the UCP1 sequence in 1985 the
establishment of mammalian test systems was attempted, suitable
for the expression of different UCP variants to analyze structure–
function-relationships. Chinese hamster ovary (CHO) cells were
stably transfected with rat UCP1. The assessment of rat UCP1
function in isolated mitochondria from these cells revealed that
they were slightly uncoupled, and respiratory control was regained
by addition of 1mM GDP. This treatment also partially restored
membrane potential, but as it did not reach the level of mito-
chondria from control cells, an uncoupling artifact as published
for yeast could not be excluded (Casteilla et al., 1990; Stuart et al.,
2001). A further limitation was that the expression level of rat
UCP1 in these mitochondria was around 1μg/mg protein and
thus much lower than in BAT mitochondria (Table 1). Transient
overexpression of UCP1 in HepG2 liver cells led to a decrease in
ATP production, but the authors did not try to quantify catalytic
activity (Gonzalez-Muniesa et al., 2005). Ectopic overexpression
of mouse UCP1 in a ﬁbroblast cell line was applied to characterize
in detail the effect on cellular metabolism. The authors found that
3T3L1 cells expressing UCP1 accumulate less lipid due to reduced
lipid synthesis,while oxygen consumption is onlymarginally stim-
ulated. Beta-oxidation and several differentiation markers are not
affected, indicating that UCP1 expression in white adipose tis-
sue might provide an approach to reduce lipid accumulation (Si
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FIGURE 1 | Dissipation of energy from nutrient combustion at the
mitochondrial inner membrane. Reduction equivalents feed electrons
into the respiratory chain, which are passed along a redox gradient and
reduce oxygen to water. Energy released by these reactions is stored as
a proton gradient across the membrane, as protons are pumped into the
intermembrane space. ATP synthase utilizes this energy and the ﬂux of
protons along the enzyme leads to the phosphorylation of ADP to ATP.
Activity of the respiratory chain and ATP synthase are coupled by the
proton gradient (coupled respiration). Coupling can be reduced by a basal
leak of protons across the membrane, present in every cell, or by an
inducible proton leak, catalyzed by speciﬁc proteins, in case of BAT
mitochondria mainly by UCP1 (uncoupled respiration). Proton
translocation by leak pathways prevents ﬁxation of energy and releases it
as heat.
et al., 2007). In another study, human UCP1 was expressed in
INS1E cells, reaching expression levels of 1–1.5μg/mg mitochon-
drial protein. UCP1 activity could be induced by addition of fatty
acids, leading to an increased respiration and lower membrane
potential (Galetti et al., 2009), whereas heterologous expression
of human UCP2 in the same system did not affect mitochondrial
bioenergetics.
Determination of UCP1 activity in mammalian mitochondria
is often performed by the analysis of cellular or mitochondrial
respiration but this gives just a rough impression of the cou-
pling state. Only when membrane potential is determined at the
same time it is possible to describe proton leak or even proton
leak kinetics, as the need for respiratory activity depends largely
on the membrane potential which has to be maintained. If two
mitochondrial preparations both consume a certain amount of
oxygen under non-phosphorylating conditions, those defending a
higher membrane potential are more coupled, a fact you would
miss by only looking at respiration. Respiration is mostly mea-
sured with Clark-type electrodes while membrane potential can
bedeterminedwithﬂuorescent dyes or electrodeswhichdetect dis-
tribution of lipophilic cations, e.g., TPMP+ (Brand, 1995). Several
steady states of membrane potential and oxygen consumption can
be titrated and plotted against each other, resulting in a curve
describing proton leak kinetics (Figure 3). Two curves can be
compared by regarding oxygen consumption (respiratory activity)
needed to maintain a certain membrane potential.
The obvious advantage of mammalian cell systems is that they
represent the natural background on which the probability of
proper folding and insertion into the membrane is higher than in
other systems, even if UCP1 is expressed in a non-brown fat cell.
In our laboratory we have generated a novel mammalian UCP1
expression model by stable transfection of HEK293 cells with an
expression vector carrying the mouse UCP1 cDNA under control
of the CMV promoter. As exempliﬁed in proton leak measure-
ments UCP1 in isolated mitochondria from these cells is activated
by the addition of palmitate (Figure 3A). Maximum transport
activity of mUCP1 was ∼75H+ s−1 (Table 1). In the presence
of GDP this activation is diminished and at 1mM GDP the pro-
ton leak of mitochondria expressing UCP1 at a level of 4.8μg/mg
mitochondrial protein is identical to the proton leak of mitochon-
dria from normal HEK293 cells. This demonstrates that stable
expression of UCP1 in these cells at the given expression level does
not cause any uncoupling artifact.
Nevertheless, one has to keep in mind that heterologous over-
expression may induce stress in a cell which may indirectly impact
mitochondrial function. Furthermore, immortalized cell culture
models usually develop altered cell physiology during the immor-
talization process which may for example switch their metabolism
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FIGURE 2 | Exemplary trace for analysis of UCP1 function in
proteoliposomes. Absorbance of safranin O is plotted against time.
Addition of nigericin at minute 1 induces polarization of the liposomes,
measured as a decrease in safranin O absorbance, if a proton translocating
pathway is present in the vesicles. Addition of CCCP at minute 3 leads to
complete polarization and indicates vesicle volume. The initial slope after
addition of nigericin is a measure for the proton translocation pathway, if
there is one present and active. UCP1 is not active under basal conditions
(UCP1) but mediates proton transport in the presence of lauric acid (LA).
This can be prevented by addition of GDP (GDP LA). Addition of lauric acid
to vesicles not containing UCP1 does not induce proton translocation (LA).
toward glycolysis, as indicated by elevated lactate production, e.g.,
in the CHO expression system (Casteilla et al., 1990).
So far no one has tested the function of human UCP1 in
a heterologous mammalian expression system. Given the many
advantages of this easy to manipulate system, future studies will
certainly remedy this surprising deﬁcit.
BROWN ADIPOCYTE CELL LINES
Stable brown preadipocyte cell lines have been generated by sev-
eral different strategies. A ﬁrst one is isolation, serial passage, and
selection of stromal vascular fraction (SVF) cells either from BAT
of wildtype mice (Forest et al., 1987) or from BAT hibernoma
of transgenic mice with adipose-speciﬁc expression of SV40 frag-
ments (Ross et al., 1992).A second strategy has been the cultivation
and SV40 immortalization of the SVF from BAT depots of indi-
vidual mouse embryos or newly born mice (Benito et al., 1993;
Klein et al., 1999). These cell lines are maintained as precur-
sor cells, but in response to hormonal stimulation differentiate
into brown adipocytes. Therefore they do not only allow analysis
of UCP1 function but can also be used to study differentiation
of brown adipocytes and regulation of UCP1 expression. The
UCP1 expression level in these cells is often low and requires
induction by activators of UCP1 transcription for functional
analyses.
Studying brown adipocyte cell lines allows analysis in a
native background with lower variation than in tissue. In
cell culture, molecular biology tools allow overexpression and
FIGURE 3 | Proton leak kinetics of isolated mitochondria. Mitochondria
from HEK UCP1 cells (A) and mitochondria from a differentiated brown
preadipocyte cell line (B). Addition of palmitate (triangle) in both systems
leads to an increase in proton leak compared to basal conditions (circle),
indicated by the upwards shift of the curve. Coincubation with GDP
(square) prevents the activation by palmitate, demonstrating that it is
mediated by UCP1. Proton conductance of HEK UCP1 mitochondria in the
presence of GDP is lower than under basal conditions, whereas
mitochondria from brown adipocytes are coupled back to basal level.
knockdown of speciﬁc factors to test their relevance as cofactors
of UCP1 function. A brown adipocyte model can be expected to
endogenously feature all interaction partners necessary for opti-
mal UCP1 function, all signaling cascades leading to its activation
and comparable metabolic characteristics, substrate speciﬁcity,
and preference. The possibility to immortalize cells from BAT SVF
of individual mice implicates that also transgenic mice can be ana-
lyzed, even from models with perinatal mortality. This allows the
generation of cell lines carrying knockout/knockin alleles, which
had been immensely challenging in the past.
A disadvantage of all cell culture lines is that they change with
increasing passage number, somehow limiting the advantage of
stability. Low levels of UCP1 expression and the necessity to treat
cells with inducing substances further increases variability.
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A recent important ﬁnding in cultured brown adipocytes does
not concern uncoupling protein function but developmental ori-
gin of the cells. It was shown that brown adipocytes and muscle
cells originate from the same progenitor, being determined to
differentiate into muscle or adipocyte by the absence or presence
of PRDM16 (Seale et al., 2007). This ﬁnding implies that brown
and white fat cells are less related than brown fat and muscle,
and underlines the energy-dissipating function of BAT in contrast
to the energy conserving function of WAT. Studies in different
cell lines have demonstrated the importance of T3, insulin and
β-adrenergic signals for brown fat differentiation, but also for
retinoids and PPARy (Klaus et al., 1994, 1995; Alvarez et al., 2000;
Nedergaard et al., 2005). Even commonly used white adipocyte
cell models, mouse embryonic ﬁbroblasts (MEF), can be induced
to express UCP1 by treatment with retinoic acid (Mercader et al.,
2010).
In our laboratory we have recently started to evaluate UCP1
function in mitochondria isolated from an immortalized brown
preadipocyte cell line (kindly provided by B. Spiegelman; Uldry
et al., 2006).After differentiation and treatmentwith isoproterenol
and retinal these cells express approximately 2.8 μg UCP1/mg
mitochondrial protein. The proton conductance of isolated mito-
chondria can be increased by the addition of palmitate and this
can be prevented by the addition of 1mM GDP indicating uncou-
pling protein function (Figure 3B). Maximum fatty acid induced
UCP1 activity was ∼90H+∗ s−1, which is in the same range as
maximum UCP1 activity in HEK cells stably expressing UCP1
(Table 1).
In 1997, a human brown preadipocyte cell line was generated
from infant BAT tissue (Zilberfarb et al., 1997). UCP1was detected
by qPCR and Northern Blot but not further characterized on the
functional level, due to low expression level. Very recently a study
on precursor cells from human adipose tissue has been published
(Lee et al., 2011). With the requirement of long culture times
ﬁbroblastic cells can be obtained from the SVF of supraclavicular
fat depots, which then can be differentiated and do contain UCP1.
No functional studies on human UCP1 have been conducted in
these cell lines.
BROWN ADIPOSE TISSUE MITOCHONDRIA FROM WILDTYPE AND
MUTANT MICE
One of the ﬁrst and still widely used approaches to character-
ize UCP1 is to measure its function and impact on proton leak
in isolated BAT mitochondria. Isolation of mitochondria makes
them accessible to inhibitory or activating substances which might
not pass the cell membrane. Furthermore it is possible to con-
trol substrate supply and to monitor membrane potential and
respiration without having to correct for cell membrane poten-
tial or non-mitochondrial oxygen consumption in the cell. Iso-
lated mitochondria were used for the identiﬁcation of UCP1
and description of its fundamental characteristics even before
it was puriﬁed or its sequence was available. Nucleotide bind-
ing of UCP1 was characterized, demonstrating pH sensitivity
and a higher afﬁnity to GDP and GTP compared to ADP and
ATP (Rial et al., 1983; Huang and Klingenberg, 1995). Studies
with isolated mitochondria also elucidated structural aspects of
UCP1. Tryptic digestion of UCP1 in isolated mitochondria, sub-
mitochondrial particles, and proteoliposomes revealed that the
C-terminus of the protein is located in the intermembrane space
(Eckerskorn and Klingenberg, 1987). Most commonly, mice, rats,
hamsters, and guinea pigs have been employed in studies with
isolated mitochondria. Comparison of BAT mitochondria from
animals exposed to different conditions, e.g., cold adapted and
kept at thermoneutrality, allowed to assess the effect of differ-
ent UCP1 amounts. Analysis of mitochondria from wildtype and
knockout mice allows clear assignment of mitochondrial char-
acteristics to the presence and function of UCP1. The creation
of transgenic mice even permits analysis of UCP1 function in
mitochondria of tissues other than BAT. Ectopically expressed
UCP1 in skeletal muscle mitochondria can be fully inhibited with
GDP and activated with fatty acids. Furthermore UCP1 seems to
be active in the resting state, as superoxide production is lower
but reaches control levels when GDP is added (Keipert et al.,
2010).
First studies assaying brown fat mitochondria mainly mon-
itored activity of UCP1 by swelling experiments (Nicholls and
Lindberg, 1973). Later measurements of respiration and mem-
branepotentialwere applied to characterize proton leak kinetics, as
described above. New technologies now facilitate studies of mito-
chondrial bioenergetics offering respirometry devices with either
high-resolution (OROBOROS Instruments) or multiwell analy-
sis of oxygen consumption and extracellular acidiﬁcation rates
(SEAHORSE BioSciences).
Given that BAT mitochondria are the native environment of
UCP1 the protein is correctly folded and assembled in this test sys-
tem. All necessary cofactors are present and the mitochondrium is
equipped to sustain high respiratory activity, enabling maximum
UCP1 activity.
In order to make use of these advantages the conditions for
mitochondrial isolation must be chosen adequately. Isolation can
damage mitochondria, most likely during homogenization of the
tissue or by inadequate buffer conditions. It was found, that only
in sufﬁciently low osmotic medium mitochondrial matrix vol-
ume expands and allows proper usage of NAD+ linked substrates
(Nicholls and Lindberg, 1972). Effects mediated by other car-
riers present in the mitochondrial inner membrane have to be
excluded by proper controls. Mitochondria come directly from
animals which introduces variation due to different life history of
different animals. Body weight, exact housing temperature, and
age are factors which have impact on mitochondrial characteris-
tics and thus have to be carefully controlled (Porter and Brand,
1993; Harper et al., 1998).
A recent discussion which was based on studies in isolated
mitochondria from wildtype and UCP1 knockout mice con-
cerned a possible contribution of UCP1 to basal proton con-
ductance in BAT mitochondria. Parker et al. (2009) found that
basal, GDP-insensitive proton leak is higher in BAT mitochon-
dria from wildtype mice compared to UCP1 knockout mice.
Shabalina et al. (2010) argued that this is not due to a contri-
bution of UCP1 to basal proton leak, but due to the assay buffer
conditions, which selectively harm mitochondria from knockout
animals.
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Table 2 | Advantages and disadvantages of different UCP1 test systems.
Advantages Disadvantages
Proteoliposomes Completely controlled environment Susceptible to variation by experimental artifacts
Absence of unknown cofactors, regulators, etc.
Planar lipid
bilayers
Completely controlled environment Susceptible to variation by experimental artifacts
High membrane potentials possible Absence of unknown cofactors, regulators, etc.
Yeast Eukaryotic environment: protein modiﬁcations,
folding, cofactors, etc.
High UCP1 levels lead to artiﬁcial uncoupling
Genetically manipulable Non-mammalian
No endogenous UCP1
Mammalian cell
lines
Natural environment for thermogenic UCP1: protein
modiﬁcations, folding, cofactors, etc.
Altered metabolic phenotypes in immortalized cells,
e.g., preferred glycolytic ATP production
High UCP1 amounts without uncoupling artifacts
possible
Accessible to molecular biology tools (overexpression,
knockdown, etc.)
Brown adipocyte
lines
As above, plus: optimal metabolic environment,
natural regulation processes, signaling pathways, and
lipid storage
As above, plus: usually low UCP1 abundance
Unstable, heterogenous cell systems
Tissue
mitochondria
Natural source of UCP1 in its in vivo setting optimized
for high respiratory activity
Sophisticated isolation procedures necessary prone
to damage mitochondria
Availability of manipulated mouse strains Time and cost intensive
From artiﬁcial to native test systems generally, there is an increase in probability of proper folding and native function with the trade off of increasing variability and
reduced possibilities to manipulate the system. Depending on the experimental question there might be a bigger need for simplicity and reproducibility or for a
physiological background, and therefore in each case another test system the best choice.
So far there are no studies analyzing humanUCP1 in BATmito-
chondria, neither in human mitochondria nor after transgenic
expression in animal mitochondria.
CONCLUSION AND PERSPECTIVES
The discovery of signiﬁcant amounts of active BAT in humans
has renewed interest in this organ and particularly in UCP1 as a
pharmacological target to treat metabolic disease. Unfortunately,
very little is known about the physiology of human BAT and
most of our supposed knowledge is actually transferred from the
study of rodents and other animals. This caveat applies to all
aspects of BAT function including neuronal and hormonal reg-
ulation, recruitment of tissue hypertrophy and hyperplasia, heat
production capacity and the cellular architecture like mitochon-
drial density and lipid droplet composition. It is equally true for
the central question we focus on in this review, the structure and
function of UCP1.
We have to keep in mind that the human UCP1 protein only
shares less than 80% identity with rodent UCP1. Together with
the protein sequences of all eutherian species it forms a group
that is markedly different from UCP1 sequences of marsupials
or other lower vertebrates (Hughes et al., 2009). It is assumed
that this large phylogenetic gap between the eutherian and lower
groups represents the acquirement of a regulated, thermogenic
function of UCP1, arguing for this very role of human UCP1. On
the other hand, as judged by allometric comparison of animals
with different masses, a species as large as man should feature only
negligible amounts of BAT, relieving selection pressure on efﬁcient
uncoupling by UCP1 (Heldmaier, 1971). Such a phenomenon can
be observed, for instance, in all species of pigs. Being of the same
size as man they have entirely lost an intact UCP1 gene (Berg
et al., 2006). Sheep and bovine, however, have retained their UCP1
genes and exhibit functional BAT at least during the postnatal
phase.
Activity and regulation of UCP1 proteins of different species
have been measured (Table 1). Unfortunately, due to the large
variation between methods and laboratories it is impossible to
dissect the contribution of a species speciﬁc difference. It is thus
essential to compare UCP1 from different species and includ-
ing human UCP1 in one test system which does not display
artifactual uncoupling due to UCP1 expression and in an exper-
imental setup with low inter-experimental variability (Table 2).
This will enable us to assess how easily our knowledge on
UCP1 function can be transferred to human BAT and pro-
vide the groundwork for the search of compounds altering this
function.
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